“The great thing in the world is not so much where we stand…as in what direction we are moving” These words sum up the efforts of Venus Pharma GmbH, which integrates people, processes and potential towards the betterment of mankind. Venus has a strong manufacturing base in parental products with focus in Oncology segment. We have a formidable portfolio of parental antibiotics and LMWH as well. Other than the WHO GMP ; Our international accreditation's include: -GMP Europe (INFARMED), GMP GCC, GMP Saudi Arabia, GMP TGA -GMP Colombia(INVIMA) -GMP Ukraine (PIC/S) -GMP Kenya, GMP Uganda,GMP Ethiopia,GMP Sudan, GMP Zimbabwe,GMP Tanzania,GMP Ivory Coast -GMP UAE,GMP Syria,GMP Yemen,GMP Iran,GMP Bahrain,GMP Botswana -GMP Indonesia,GMP Nepal Venus Pharma GmbH(VPG) is into marketing operations for Injectable products and Research products. Regulated Markets of EU,GCC-MENA and Emerging/ROW Markets of FWA ,Eastern Europe ,CIS are being managed by VPG. Our Winning Team bring laurels: - Venus Pharma is perhaps the largest supplier of Meropenen in EU. Major Market share in Germany,Italy,UK, Cyprus,Portugal,Israel,Latvia,Iceland. - Truly amazing; Venus Pharma will partner NHS to supply Gemcitabine Injections(Oncology) to all the 3 Regions in 2018-2019 - Spreadings wings out of EU: Expanding in MENA regions specially in Lebanon, Morocco, Nigeria, Bahrain,Qatar. - New projects initiated in Chile & Botswana. New Customer acquisitions for QA-QC Testing & Batch release Laboratory underway. Connect with our multilingual team that speaks ENGLISH/GERMAN/FRENCH , connect with the Associate Vice President directly for business opportunities: e-mail: vc@venuspharmagmbh.de ( Mr.VISHAL CHANDRA)